FDA Drug Approval and the Ethics of Desperation

This Viewpoint uses the accelerated approval of aducanumab to treat Alzheimer disease to discuss what role patient desperation should play in the FDA ’s decision-making.
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research